Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Celsion Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Celsion Corp, Medical Devices Deals, 2011 to YTD 2017 10
Celsion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Celsion Corp, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Celsion Enters into Partnership with Children’s Research Institute 13
Celsion Enters into Agreement with Zhejiang Hisun Pharma 14
Celsion Expands Technology Development Agreement With Zhejiang Hisun Pharma 15
Celsion Enters Into Technology Development Agreement With Zhejiang Hisun Pharma For ThermoDox 16
Licensing Agreements 18
Celsion Enters Into Licensing Agreement With Duke University 18
Equity Offering 19
Celsion Plans to Raise up to USD7.4 Million in Private Placement of Shares up on Exercise of Warrants 19
Celsion Prices Public Offering of Shares for USD6.6 Million 20
Celsion Plans to Raise Funds through Private Placement of Shares up on Exercise of Warrants 21
Celsion Raises USD4.2 Million in Private Placement of Shares and Warrants 22
Celsion to Raise up to USD2.4 Million in Public Offering of Shares 24
Celsion Raises Funds through Private Placement of Shares upon Exercise of Warrants 25
Celsion Raises USD0.6 Million in Private Placement of Shares upon Exercise of Warrants 26
Celsion Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 27
Celsion Raises USD5 Million in Public Offering of Shares and Warrants 28
Celsion Raises USD1.8 Million in Private Placement of Shares and Warrants 29
Celsion Plans to Raise USD12.3 Million in Private Placement of Shares upon Exercise of Warrants 30
Celsion Raises Funds through Private Placement of Shares up on Exercise of Warrants 31
Celsion Raises USD6 Million in Private Placement of Shares 32
Celsion Raises USD8 Million in Private Placement of Shares 33
Celsion Announces Private Placement Of Common Stock For US$15 Million 34
Celsion Raises USD9.8 Million in Private Placement of Shares 35
Celsion Completes Private Placement Of Shares For US$15 Million 36
Celsion Completes Public Offering Of Common Stock For US$7 Million 37
Celsion Completes Registered Direct Offering Of Common Stock For US$15 Million 38
Celsion Completes Registered Direct Offering Of Units For US$13 Million 39
Celsion Completes Registered Direct Offering Of Units For US$5.6 Million 40
Celsion Completes Registered Direct Offering Of US$6.6 Million 41
Celsion Completes Private Placement Of US$8.53 Million 43
Celsion Completes Registered Direct Offering Of Units For US$5.1 Million 44
Acquisition 46
Celsion Completes Acquisition of Egen Biopharma Company 46
Celsion Explores Acquisition Opportunities 48
Celsion Corp – Key Competitors 49
Celsion Corp – Key Employees 50
Celsion Corp – Locations And Subsidiaries 51
Head Office 51
Recent Developments 52
Financial Announcements 52
Nov 14, 2017: Celsion Reports Third Quarter 2017 Financial Results and Provides Business Update 52
Aug 15, 2017: Celsion Reports Second Quarter 2017 Financial Results and Provides Business Update 55
May 12, 2017: Celsion Reports First Quarter 2017 Financial Results and Provides Business Update 58
Mar 16, 2017: Celsion Reports Year End 2016 Financial Results and Provides Business Update 60
Nov 10, 2016: Celsion Reports Third Quarter 2016 Financial Results 62
Aug 15, 2016: Celsion Reports Second Quarter 2016 Financial Results and Provides Business Update 64
May 16, 2016: Celsion Reports First Quarter 2016 Financial Results and Provides Business Update 66
Mar 30, 2016: Celsion Reports Year End 2015 Financial Results and Provides Business Update 68
Corporate Communications 70
Aug 04, 2017: Celsion to Delist from the Tel Aviv Stock Exchange 70
Product News 71
04/12/2016: Celsion Announces Upcoming Presentation at AACR 2016 Highlighting Potential of GEN-1 IL-12 Immunotherapy in Ovarian Cancer 71
Clinical Trials 72
May 24, 2016: Celsion Announces Presentation of OVATION Study Clinical Trial Design at Upcoming ASCO 2016 Meeting 72
May 02, 2016: Celsion Announces Positive Data from the First Cohort of Patients in the OVATION Study 74
Apr 26, 2016: Celsion Announces Enrollment of First Patient in the OPTIMA Study in China 76
Apr 19, 2016: Celsion Presents Compelling Data at AACR 2016 Demonstrating Synergistic Anti-Cancer Effect of GEN-1 IL-12 Immunotherapy Plus Avastin and Doxil 77
Mar 16, 2016: Celsion Announces Presentation of Preclinical Data for GEN-1 IL-12 Immunotherapy in Combination with Avastin and Doxil at the AACR Annual Meeting 2016 78
Mar 07, 2016: Celsion Announces Launch of the OPTIMA Study in China 80
Feb 12, 2016: Celsion Highlights Recent Pipeline Developments for its GEN-1 Immunotherapy Program and Provides Business Update 81
Jan 07, 2016: Celsion Reports Translational Research Data from its Phase 1b Study of GEN-1 Immunotherapy in Recurrent Ovarian Cancer 83
Appendix 84
Methodology 84
About GlobalData 84
Contact Us 84
Disclaimer 84
Celsion Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Celsion Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Celsion Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Celsion Corp, Medical Devices Deals, 2011 to YTD 2017 10
Celsion Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Celsion Enters into Partnership with Children's Research Institute 13
Celsion Enters into Agreement with Zhejiang Hisun Pharma 14
Celsion Expands Technology Development Agreement With Zhejiang Hisun Pharma 15
Celsion Enters Into Technology Development Agreement With Zhejiang Hisun Pharma For ThermoDox 16
Celsion Enters Into Licensing Agreement With Duke University 18
Celsion Plans to Raise up to USD7.4 Million in Private Placement of Shares up on Exercise of Warrants 19
Celsion Prices Public Offering of Shares for USD6.6 Million 20
Celsion Plans to Raise Funds through Private Placement of Shares up on Exercise of Warrants 21
Celsion Raises USD4.2 Million in Private Placement of Shares and Warrants 22
Celsion to Raise up to USD2.4 Million in Public Offering of Shares 24
Celsion Raises Funds through Private Placement of Shares upon Exercise of Warrants 25
Celsion Raises USD0.6 Million in Private Placement of Shares upon Exercise of Warrants 26
Celsion Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 27
Celsion Raises USD5 Million in Public Offering of Shares and Warrants 28
Celsion Raises USD1.8 Million in Private Placement of Shares and Warrants 29
Celsion Plans to Raise USD12.3 Million in Private Placement of Shares upon Exercise of Warrants 30
Celsion Raises Funds through Private Placement of Shares up on Exercise of Warrants 31
Celsion Raises USD6 Million in Private Placement of Shares 32
Celsion Raises USD8 Million in Private Placement of Shares 33
Celsion Announces Private Placement Of Common Stock For US$15 Million 34
Celsion Raises USD9.8 Million in Private Placement of Shares 35
Celsion Completes Private Placement Of Shares For US$15 Million 36
Celsion Completes Public Offering Of Common Stock For US$7 Million 37
Celsion Completes Registered Direct Offering Of Common Stock For US$15 Million 38
Celsion Completes Registered Direct Offering Of Units For US$13 Million 39
Celsion Completes Registered Direct Offering Of Units For US$5.6 Million 40
Celsion Completes Registered Direct Offering Of US$6.6 Million 41
Celsion Completes Private Placement Of US$8.53 Million 43
Celsion Completes Registered Direct Offering Of Units For US$5.1 Million 44
Celsion Completes Acquisition of Egen Biopharma Company 46
Celsion Explores Acquisition Opportunities 48
Celsion Corp, Key Competitors 49
Celsion Corp, Key Employees 50
